Loading…

The benefits and risks of non‐steroidal anti‐inflammatory drugs for postoperative analgesia in sinonasal surgery: a systematic review and meta‐analysis

Background Non‐steroidal anti‐inflammatory drugs (NSAIDs) have emerged as an alternative to opioids for optimal postoperative pain management. However, the adoption of NSAIDs in sinonasal surgery has been impeded by a theoretical concern for postoperative bleeding. Our objective is to systematically...

Full description

Saved in:
Bibliographic Details
Published in:International forum of allergy & rhinology 2023-09, Vol.13 (9), p.1738-1757
Main Authors: Lee, Daniel J., Grose, Elysia, Brenna, Connor T. A., Philteos, Justine, Lightfoot, David, Kirubalingam, Keshinisuthan, Chan, Yvonne, Palmer, James N., Adappa, Nithin D., Lee, John M.
Format: Article
Language:English
Subjects:
Citations: Items that this one cites
Items that cite this one
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
cited_by cdi_FETCH-LOGICAL-c3880-86208fa6ffe5117ca5496efdc43fe98e417fffe23acd7d2099de6c99d198da53
cites cdi_FETCH-LOGICAL-c3880-86208fa6ffe5117ca5496efdc43fe98e417fffe23acd7d2099de6c99d198da53
container_end_page 1757
container_issue 9
container_start_page 1738
container_title International forum of allergy & rhinology
container_volume 13
creator Lee, Daniel J.
Grose, Elysia
Brenna, Connor T. A.
Philteos, Justine
Lightfoot, David
Kirubalingam, Keshinisuthan
Chan, Yvonne
Palmer, James N.
Adappa, Nithin D.
Lee, John M.
description Background Non‐steroidal anti‐inflammatory drugs (NSAIDs) have emerged as an alternative to opioids for optimal postoperative pain management. However, the adoption of NSAIDs in sinonasal surgery has been impeded by a theoretical concern for postoperative bleeding. Our objective is to systematically review the efficacy and safety of NSAIDs for patients undergoing sinonasal surgery. Methods MEDLINE, EMBASE, the Cochrane Central Register of Controlled Trials, CINAHL, and the WHO International Clinical Trials Registry Platform were searched from inception to January 27, 2022. Randomized controlled trials (RCTs) and comparative observational studies in any language were considered. Screening, data extraction, and risk of bias assessment were performed in duplicate. Our outcomes were postoperative pain scores, requirement for rescue analgesia, and postoperative adverse events (epistaxis, nausea/vomiting). Results Out of 4661 records, 15 RCTs (enrolling 1210 patients) and two observational studies were included. Following endoscopic sinus surgery, there was no difference in pain scores between NSAIDs and non‐NSAIDs groups (standardized mean differences [SMD] 0.44 units better, 95% CI –0.18 to 1.05). Following septorhinoplasty, NSAIDs decreased pain scores compared to non‐NSAID regimens (SMD 1.14 units better, 95% CI 0.61 to 1.67 units better). Overall, NSAIDs reduced the need for rescue medication with a relative risk (RR) of 0.45 (95% CI 0.24 to 0.84). In addition, NSAIDs decreased the risk of nausea with an RR of 0.62 (95% CI 0.42 to 0.91) and did not increase the risk of epistaxis (RR 0.72, 95% CI 0.23‐2.22). Conclusion Among patients undergoing sinonasal surgery, NSAIDs are beneficial in postoperative pain management and avoidance of postoperative nausea without increasing the risk of postoperative epistaxis.
doi_str_mv 10.1002/alr.23140
format article
fullrecord <record><control><sourceid>proquest_cross</sourceid><recordid>TN_cdi_proquest_miscellaneous_2775618292</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>2854855740</sourcerecordid><originalsourceid>FETCH-LOGICAL-c3880-86208fa6ffe5117ca5496efdc43fe98e417fffe23acd7d2099de6c99d198da53</originalsourceid><addsrcrecordid>eNp1kc9u1DAQhy0EolXpgRdAlrjAYVvbif-EW1VRQFoJCe09msbjxSWJF0_SKrc-Ai_Ay_VJcLulByR8sC3PN99Y-jH2WooTKYQ6hT6fqErW4hk7VKJWK9O4-vnT3ZoDdkx0JcrSUmtpX7KDylijrJSH7PfmO_JLHDHEiTiMnudIP4inwMc03t3-oglzih76UpxieYhj6GEYYEp54T7PW-IhZb5LNKUdZpjiNRYW-i1SBB5HTrGogIqC5rzFvHzgwGkp5mKJHc94HfHmYfiAE5QZ9-0LRXrFXgToCY8fzyO2ufi4Of-8Wn_99OX8bL3qKufEyhklXAATAmopbQe6bgwG39VVwMZhLW0oNVVB561Xomk8mq7ssnEedHXE3u21u5x-zkhTO0TqsO9hxDRTq6zVRjrVqIK-_Qe9SnMu3y2U07XT2taiUO_3VJcTUcbQ7nIcIC-tFO19am1JrX1IrbBvHo3z5YD-ifybUQFO98BN7HH5v6k9W3_bK_8AlcOnsw</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>2854855740</pqid></control><display><type>article</type><title>The benefits and risks of non‐steroidal anti‐inflammatory drugs for postoperative analgesia in sinonasal surgery: a systematic review and meta‐analysis</title><source>Wiley-Blackwell Journals</source><creator>Lee, Daniel J. ; Grose, Elysia ; Brenna, Connor T. A. ; Philteos, Justine ; Lightfoot, David ; Kirubalingam, Keshinisuthan ; Chan, Yvonne ; Palmer, James N. ; Adappa, Nithin D. ; Lee, John M.</creator><creatorcontrib>Lee, Daniel J. ; Grose, Elysia ; Brenna, Connor T. A. ; Philteos, Justine ; Lightfoot, David ; Kirubalingam, Keshinisuthan ; Chan, Yvonne ; Palmer, James N. ; Adappa, Nithin D. ; Lee, John M.</creatorcontrib><description>Background Non‐steroidal anti‐inflammatory drugs (NSAIDs) have emerged as an alternative to opioids for optimal postoperative pain management. However, the adoption of NSAIDs in sinonasal surgery has been impeded by a theoretical concern for postoperative bleeding. Our objective is to systematically review the efficacy and safety of NSAIDs for patients undergoing sinonasal surgery. Methods MEDLINE, EMBASE, the Cochrane Central Register of Controlled Trials, CINAHL, and the WHO International Clinical Trials Registry Platform were searched from inception to January 27, 2022. Randomized controlled trials (RCTs) and comparative observational studies in any language were considered. Screening, data extraction, and risk of bias assessment were performed in duplicate. Our outcomes were postoperative pain scores, requirement for rescue analgesia, and postoperative adverse events (epistaxis, nausea/vomiting). Results Out of 4661 records, 15 RCTs (enrolling 1210 patients) and two observational studies were included. Following endoscopic sinus surgery, there was no difference in pain scores between NSAIDs and non‐NSAIDs groups (standardized mean differences [SMD] 0.44 units better, 95% CI –0.18 to 1.05). Following septorhinoplasty, NSAIDs decreased pain scores compared to non‐NSAID regimens (SMD 1.14 units better, 95% CI 0.61 to 1.67 units better). Overall, NSAIDs reduced the need for rescue medication with a relative risk (RR) of 0.45 (95% CI 0.24 to 0.84). In addition, NSAIDs decreased the risk of nausea with an RR of 0.62 (95% CI 0.42 to 0.91) and did not increase the risk of epistaxis (RR 0.72, 95% CI 0.23‐2.22). Conclusion Among patients undergoing sinonasal surgery, NSAIDs are beneficial in postoperative pain management and avoidance of postoperative nausea without increasing the risk of postoperative epistaxis.</description><identifier>ISSN: 2042-6976</identifier><identifier>EISSN: 2042-6984</identifier><identifier>DOI: 10.1002/alr.23140</identifier><identifier>PMID: 36762711</identifier><language>eng</language><publisher>United States: Wiley Subscription Services, Inc</publisher><subject>Analgesia ; Clinical trials ; endoscopic sinus surgery ; Epistaxis ; Inflammation ; Meta-analysis ; Nausea ; Nonsteroidal anti-inflammatory drugs ; NSAIDs ; Observational studies ; Pain management ; Pain perception ; Paranasal sinus ; Patients ; rhinoplasty ; Surgery ; Vomiting</subject><ispartof>International forum of allergy &amp; rhinology, 2023-09, Vol.13 (9), p.1738-1757</ispartof><rights>2023 ARS‐AAOA, LLC.</rights><rights>This article is protected by copyright. All rights reserved.</rights><lds50>peer_reviewed</lds50><oa>free_for_read</oa><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c3880-86208fa6ffe5117ca5496efdc43fe98e417fffe23acd7d2099de6c99d198da53</citedby><cites>FETCH-LOGICAL-c3880-86208fa6ffe5117ca5496efdc43fe98e417fffe23acd7d2099de6c99d198da53</cites><orcidid>0000-0003-4057-2858 ; 0000-0002-3054-3474 ; 0000-0002-6126-3897</orcidid></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktopdf>$$Uhttps://onlinelibrary.wiley.com/doi/pdf/10.1002%2Falr.23140$$EPDF$$P50$$Gwiley$$Hfree_for_read</linktopdf><linktohtml>$$Uhttps://onlinelibrary.wiley.com/doi/full/10.1002%2Falr.23140$$EHTML$$P50$$Gwiley$$Hfree_for_read</linktohtml><link.rule.ids>315,786,790,27957,27958,50923,51032</link.rule.ids><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/36762711$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Lee, Daniel J.</creatorcontrib><creatorcontrib>Grose, Elysia</creatorcontrib><creatorcontrib>Brenna, Connor T. A.</creatorcontrib><creatorcontrib>Philteos, Justine</creatorcontrib><creatorcontrib>Lightfoot, David</creatorcontrib><creatorcontrib>Kirubalingam, Keshinisuthan</creatorcontrib><creatorcontrib>Chan, Yvonne</creatorcontrib><creatorcontrib>Palmer, James N.</creatorcontrib><creatorcontrib>Adappa, Nithin D.</creatorcontrib><creatorcontrib>Lee, John M.</creatorcontrib><title>The benefits and risks of non‐steroidal anti‐inflammatory drugs for postoperative analgesia in sinonasal surgery: a systematic review and meta‐analysis</title><title>International forum of allergy &amp; rhinology</title><addtitle>Int Forum Allergy Rhinol</addtitle><description>Background Non‐steroidal anti‐inflammatory drugs (NSAIDs) have emerged as an alternative to opioids for optimal postoperative pain management. However, the adoption of NSAIDs in sinonasal surgery has been impeded by a theoretical concern for postoperative bleeding. Our objective is to systematically review the efficacy and safety of NSAIDs for patients undergoing sinonasal surgery. Methods MEDLINE, EMBASE, the Cochrane Central Register of Controlled Trials, CINAHL, and the WHO International Clinical Trials Registry Platform were searched from inception to January 27, 2022. Randomized controlled trials (RCTs) and comparative observational studies in any language were considered. Screening, data extraction, and risk of bias assessment were performed in duplicate. Our outcomes were postoperative pain scores, requirement for rescue analgesia, and postoperative adverse events (epistaxis, nausea/vomiting). Results Out of 4661 records, 15 RCTs (enrolling 1210 patients) and two observational studies were included. Following endoscopic sinus surgery, there was no difference in pain scores between NSAIDs and non‐NSAIDs groups (standardized mean differences [SMD] 0.44 units better, 95% CI –0.18 to 1.05). Following septorhinoplasty, NSAIDs decreased pain scores compared to non‐NSAID regimens (SMD 1.14 units better, 95% CI 0.61 to 1.67 units better). Overall, NSAIDs reduced the need for rescue medication with a relative risk (RR) of 0.45 (95% CI 0.24 to 0.84). In addition, NSAIDs decreased the risk of nausea with an RR of 0.62 (95% CI 0.42 to 0.91) and did not increase the risk of epistaxis (RR 0.72, 95% CI 0.23‐2.22). Conclusion Among patients undergoing sinonasal surgery, NSAIDs are beneficial in postoperative pain management and avoidance of postoperative nausea without increasing the risk of postoperative epistaxis.</description><subject>Analgesia</subject><subject>Clinical trials</subject><subject>endoscopic sinus surgery</subject><subject>Epistaxis</subject><subject>Inflammation</subject><subject>Meta-analysis</subject><subject>Nausea</subject><subject>Nonsteroidal anti-inflammatory drugs</subject><subject>NSAIDs</subject><subject>Observational studies</subject><subject>Pain management</subject><subject>Pain perception</subject><subject>Paranasal sinus</subject><subject>Patients</subject><subject>rhinoplasty</subject><subject>Surgery</subject><subject>Vomiting</subject><issn>2042-6976</issn><issn>2042-6984</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2023</creationdate><recordtype>article</recordtype><sourceid>24P</sourceid><sourceid>WIN</sourceid><recordid>eNp1kc9u1DAQhy0EolXpgRdAlrjAYVvbif-EW1VRQFoJCe09msbjxSWJF0_SKrc-Ai_Ay_VJcLulByR8sC3PN99Y-jH2WooTKYQ6hT6fqErW4hk7VKJWK9O4-vnT3ZoDdkx0JcrSUmtpX7KDylijrJSH7PfmO_JLHDHEiTiMnudIP4inwMc03t3-oglzih76UpxieYhj6GEYYEp54T7PW-IhZb5LNKUdZpjiNRYW-i1SBB5HTrGogIqC5rzFvHzgwGkp5mKJHc94HfHmYfiAE5QZ9-0LRXrFXgToCY8fzyO2ufi4Of-8Wn_99OX8bL3qKufEyhklXAATAmopbQe6bgwG39VVwMZhLW0oNVVB561Xomk8mq7ssnEedHXE3u21u5x-zkhTO0TqsO9hxDRTq6zVRjrVqIK-_Qe9SnMu3y2U07XT2taiUO_3VJcTUcbQ7nIcIC-tFO19am1JrX1IrbBvHo3z5YD-ifybUQFO98BN7HH5v6k9W3_bK_8AlcOnsw</recordid><startdate>202309</startdate><enddate>202309</enddate><creator>Lee, Daniel J.</creator><creator>Grose, Elysia</creator><creator>Brenna, Connor T. A.</creator><creator>Philteos, Justine</creator><creator>Lightfoot, David</creator><creator>Kirubalingam, Keshinisuthan</creator><creator>Chan, Yvonne</creator><creator>Palmer, James N.</creator><creator>Adappa, Nithin D.</creator><creator>Lee, John M.</creator><general>Wiley Subscription Services, Inc</general><scope>24P</scope><scope>WIN</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>K9.</scope><scope>7X8</scope><orcidid>https://orcid.org/0000-0003-4057-2858</orcidid><orcidid>https://orcid.org/0000-0002-3054-3474</orcidid><orcidid>https://orcid.org/0000-0002-6126-3897</orcidid></search><sort><creationdate>202309</creationdate><title>The benefits and risks of non‐steroidal anti‐inflammatory drugs for postoperative analgesia in sinonasal surgery: a systematic review and meta‐analysis</title><author>Lee, Daniel J. ; Grose, Elysia ; Brenna, Connor T. A. ; Philteos, Justine ; Lightfoot, David ; Kirubalingam, Keshinisuthan ; Chan, Yvonne ; Palmer, James N. ; Adappa, Nithin D. ; Lee, John M.</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c3880-86208fa6ffe5117ca5496efdc43fe98e417fffe23acd7d2099de6c99d198da53</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2023</creationdate><topic>Analgesia</topic><topic>Clinical trials</topic><topic>endoscopic sinus surgery</topic><topic>Epistaxis</topic><topic>Inflammation</topic><topic>Meta-analysis</topic><topic>Nausea</topic><topic>Nonsteroidal anti-inflammatory drugs</topic><topic>NSAIDs</topic><topic>Observational studies</topic><topic>Pain management</topic><topic>Pain perception</topic><topic>Paranasal sinus</topic><topic>Patients</topic><topic>rhinoplasty</topic><topic>Surgery</topic><topic>Vomiting</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Lee, Daniel J.</creatorcontrib><creatorcontrib>Grose, Elysia</creatorcontrib><creatorcontrib>Brenna, Connor T. A.</creatorcontrib><creatorcontrib>Philteos, Justine</creatorcontrib><creatorcontrib>Lightfoot, David</creatorcontrib><creatorcontrib>Kirubalingam, Keshinisuthan</creatorcontrib><creatorcontrib>Chan, Yvonne</creatorcontrib><creatorcontrib>Palmer, James N.</creatorcontrib><creatorcontrib>Adappa, Nithin D.</creatorcontrib><creatorcontrib>Lee, John M.</creatorcontrib><collection>Open Access: Wiley-Blackwell Open Access Journals</collection><collection>Wiley Online Library</collection><collection>PubMed</collection><collection>CrossRef</collection><collection>ProQuest Health &amp; Medical Complete (Alumni)</collection><collection>MEDLINE - Academic</collection><jtitle>International forum of allergy &amp; rhinology</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Lee, Daniel J.</au><au>Grose, Elysia</au><au>Brenna, Connor T. A.</au><au>Philteos, Justine</au><au>Lightfoot, David</au><au>Kirubalingam, Keshinisuthan</au><au>Chan, Yvonne</au><au>Palmer, James N.</au><au>Adappa, Nithin D.</au><au>Lee, John M.</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>The benefits and risks of non‐steroidal anti‐inflammatory drugs for postoperative analgesia in sinonasal surgery: a systematic review and meta‐analysis</atitle><jtitle>International forum of allergy &amp; rhinology</jtitle><addtitle>Int Forum Allergy Rhinol</addtitle><date>2023-09</date><risdate>2023</risdate><volume>13</volume><issue>9</issue><spage>1738</spage><epage>1757</epage><pages>1738-1757</pages><issn>2042-6976</issn><eissn>2042-6984</eissn><notes>Daniel J. Lee and Elysia Grose shared co‐first authorship.</notes><notes>Daniel J. Lee accepted for Podium Presentation for 2023 American Rhinology Society Meeting at Combined Otolaryngology Spring Meetings.</notes><notes>ObjectType-Article-2</notes><notes>SourceType-Scholarly Journals-1</notes><notes>ObjectType-Feature-1</notes><notes>content type line 23</notes><notes>ObjectType-Undefined-3</notes><abstract>Background Non‐steroidal anti‐inflammatory drugs (NSAIDs) have emerged as an alternative to opioids for optimal postoperative pain management. However, the adoption of NSAIDs in sinonasal surgery has been impeded by a theoretical concern for postoperative bleeding. Our objective is to systematically review the efficacy and safety of NSAIDs for patients undergoing sinonasal surgery. Methods MEDLINE, EMBASE, the Cochrane Central Register of Controlled Trials, CINAHL, and the WHO International Clinical Trials Registry Platform were searched from inception to January 27, 2022. Randomized controlled trials (RCTs) and comparative observational studies in any language were considered. Screening, data extraction, and risk of bias assessment were performed in duplicate. Our outcomes were postoperative pain scores, requirement for rescue analgesia, and postoperative adverse events (epistaxis, nausea/vomiting). Results Out of 4661 records, 15 RCTs (enrolling 1210 patients) and two observational studies were included. Following endoscopic sinus surgery, there was no difference in pain scores between NSAIDs and non‐NSAIDs groups (standardized mean differences [SMD] 0.44 units better, 95% CI –0.18 to 1.05). Following septorhinoplasty, NSAIDs decreased pain scores compared to non‐NSAID regimens (SMD 1.14 units better, 95% CI 0.61 to 1.67 units better). Overall, NSAIDs reduced the need for rescue medication with a relative risk (RR) of 0.45 (95% CI 0.24 to 0.84). In addition, NSAIDs decreased the risk of nausea with an RR of 0.62 (95% CI 0.42 to 0.91) and did not increase the risk of epistaxis (RR 0.72, 95% CI 0.23‐2.22). Conclusion Among patients undergoing sinonasal surgery, NSAIDs are beneficial in postoperative pain management and avoidance of postoperative nausea without increasing the risk of postoperative epistaxis.</abstract><cop>United States</cop><pub>Wiley Subscription Services, Inc</pub><pmid>36762711</pmid><doi>10.1002/alr.23140</doi><tpages>20</tpages><orcidid>https://orcid.org/0000-0003-4057-2858</orcidid><orcidid>https://orcid.org/0000-0002-3054-3474</orcidid><orcidid>https://orcid.org/0000-0002-6126-3897</orcidid><oa>free_for_read</oa></addata></record>
fulltext fulltext
identifier ISSN: 2042-6976
ispartof International forum of allergy & rhinology, 2023-09, Vol.13 (9), p.1738-1757
issn 2042-6976
2042-6984
language eng
recordid cdi_proquest_miscellaneous_2775618292
source Wiley-Blackwell Journals
subjects Analgesia
Clinical trials
endoscopic sinus surgery
Epistaxis
Inflammation
Meta-analysis
Nausea
Nonsteroidal anti-inflammatory drugs
NSAIDs
Observational studies
Pain management
Pain perception
Paranasal sinus
Patients
rhinoplasty
Surgery
Vomiting
title The benefits and risks of non‐steroidal anti‐inflammatory drugs for postoperative analgesia in sinonasal surgery: a systematic review and meta‐analysis
url http://sfxeu10.hosted.exlibrisgroup.com/loughborough?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2024-09-22T10%3A27%3A45IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_cross&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=The%20benefits%20and%20risks%20of%20non%E2%80%90steroidal%20anti%E2%80%90inflammatory%20drugs%20for%20postoperative%20analgesia%20in%20sinonasal%20surgery:%20a%20systematic%20review%20and%20meta%E2%80%90analysis&rft.jtitle=International%20forum%20of%20allergy%20&%20rhinology&rft.au=Lee,%20Daniel%20J.&rft.date=2023-09&rft.volume=13&rft.issue=9&rft.spage=1738&rft.epage=1757&rft.pages=1738-1757&rft.issn=2042-6976&rft.eissn=2042-6984&rft_id=info:doi/10.1002/alr.23140&rft_dat=%3Cproquest_cross%3E2854855740%3C/proquest_cross%3E%3Cgrp_id%3Ecdi_FETCH-LOGICAL-c3880-86208fa6ffe5117ca5496efdc43fe98e417fffe23acd7d2099de6c99d198da53%3C/grp_id%3E%3Coa%3E%3C/oa%3E%3Curl%3E%3C/url%3E&rft_id=info:oai/&rft_pqid=2854855740&rft_id=info:pmid/36762711&rfr_iscdi=true